Ati cautat: interactiuni medicamente
Protocol terapeutic: J05AX12 – DCI DOLUTEGRAVIRUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N03AX17 – DCI STIRIPENTOLUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Cercetatorii, tot mai aproape de tratamentul bolii Parkinson
Conferinta Nationala de Farmacie
Protocol terapeutic: L020F – DCI BUPROPIONUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N016F – DCI CLOZAPINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N014F – DCI DULOXETINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N013F – DCI VENLAFAXINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N012F – DCI LAMOTRIGINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N011F – DCI TIANEPTINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
